Psychedelic psilocybin cuts cravings and boosts key brain functions in rat models of alcohol use disorder.

Researchers at the University of Heidelberg treated rat models of alcohol addiction with the active ingredient in magic mushrooms, psilocybin, and found that the psychedelic restored expression of a glutamate receptor called mGluR2. That reduced cravings and improved executive functioning, they found. [ABSTRACT FROM AUTHOR]

Copyright of FierceBiotech is the property of Questex Media Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)